{"address1": "12130 Mora Dr.", "address2": "Unit 2", "city": "Santa Fe Springs", "state": "CA", "zip": "90670", "country": "United States", "phone": "833 246 2633", "website": "https://www.apbiocode.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. In addition, It develops assays, such as BioCode SARS-CoV-2 Assay, a high volume automated nucleic acid multiplex assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; BioCode Respiratory Pathogen Panels, which simultaneously detects and differentiates the presence of 17 respiratory pathogens in nasopharyngeal swabs; BioCode gastrointestinal (GI) pathogen panels for common GI pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea; and MDx assays pipeline for various molecular tests. Further, the company offers fungal pathogen analyte specific reagents; human cytokine/chemokine multiplex kits to identify relevant biomarkers; mouse premixed multiplex kits and custom panels for enhancing flexibility in experimental design allowing the user to pick and choose their own analytes panel; and rat, monkey, canine, and non-human primate cytokine/chemokine multiplex kits. Additionally, the company provides BMB, calibration beads, and coupling kits for various bioassay applications; ELISA, a tool for the quantitative measurement of drug/protein/antibody levels in biological samples comprising cell lysate or serum; and various assay development services. Applied BioCode Corporation is based in Santa Fe Springs, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher M.  Bernard", "age": 54, "title": "Chief Exec. Officer", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Winston Z.  Ho Ph.D.", "title": "Founder, CTO & Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaca Liang-Kai  Huang", "title": "CFO & Corp. Governance Officer", "fiscalYear": 2020, "totalPay": 6167000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerald  Kowalski", "title": "VP of Operations", "fiscalYear": 2020, "totalPay": 5768000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jau-Tung  Pan", "title": "Accounting Supervisor", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Aye Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Yu-Tsung  Chou", "title": "Chief Information Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Parisa  Hanachi Ph.D.", "title": "VP of Marketing", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jim  Leigh", "title": "VP of Sales", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Julian  Sanchez", "title": "Sr. Director of HR", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1609372800, "maxAge": 86400, "priceHint": 2, "previousClose": 27.2, "open": 27.2, "dayLow": 27.0, "dayHigh": 27.2, "regularMarketPreviousClose": 27.2, "regularMarketOpen": 27.2, "regularMarketDayLow": 27.0, "regularMarketDayHigh": 27.2, "payoutRatio": 0.0, "beta": 0.47207, "forwardPE": -16.875, "volume": 55144, "regularMarketVolume": 55144, "averageVolume": 164064, "averageVolume10days": 54003, "averageDailyVolume10Day": 54003, "bid": 27.0, "ask": 27.1, "marketCap": 2207600896, "fiftyTwoWeekLow": 23.2, "fiftyTwoWeekHigh": 37.85, "priceToSalesTrailing12Months": 5.656135, "fiftyDayAverage": 28.551, "twoHundredDayAverage": 28.425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "TWD", "enterpriseValue": 1486713216, "profitMargins": -0.47331002, "sharesOutstanding": 81763000, "heldPercentInsiders": 0.42503, "heldPercentInstitutions": 0.00045000002, "bookValue": 9.981, "priceToBook": 2.7051399, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "netIncomeToCommon": -184732992, "trailingEps": -2.26, "forwardEps": -1.6, "enterpriseToRevenue": 3.809, "enterpriseToEbitda": -9.79, "exchange": "TAI", "quoteType": "EQUITY", "symbol": "6598.TW", "underlyingSymbol": "6598.TW", "shortName": "APPLIED BIOCODE CORPORATION", "longName": "Applied BioCode Corporation", "firstTradeDateEpochUtc": 1486602000, "timeZoneFullName": "Asia/Taipei", "timeZoneShortName": "CST", "uuid": "8203abf6-e1d1-3ae8-ad21-6704b1e0c952", "gmtOffSetMilliseconds": 28800000, "currentPrice": 27.0, "recommendationKey": "none", "totalCash": 831321984, "totalCashPerShare": 10.167, "ebitda": -151854000, "totalDebt": 49112000, "quickRatio": 10.295, "currentRatio": 11.575, "totalRevenue": 390302016, "debtToEquity": 6.018, "revenuePerShare": 4.774, "returnOnAssets": -0.107889995, "returnOnEquity": -0.21493, "freeCashflow": -56401500, "operatingCashflow": 145871008, "revenueGrowth": 0.102, "grossMargins": 0.59997004, "ebitdaMargins": -0.38907, "operatingMargins": -0.49347, "financialCurrency": "TWD", "trailingPegRatio": null}